Maxcyte (MXCT) Intangibles (2025 - 2026)
Maxcyte (MXCT) posted quarterly Intangibles of $783000.0 for Q1 2026, up 20.46% year-over-year from $650000.0 in Q1 2025, and up 20.46% quarter-over-quarter from $650000.0 in Q4 2025.
Maxcyte (MXCT) Intangibles (2025 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Intangibles for 2 consecutive years, with $783000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles rose 20.46% year-over-year to $783000.0; the TTM figure through Mar 2026 stood at $783000.0 (up 20.46% YoY), while the FY2025 annual figure was $650000.0, changed N/A from the prior year.
- Intangibles advanced to $783000.0 in Q1 2026 per MXCT's latest filing, from $650000.0 in the prior quarter.
- Across five years, Intangibles topped out at $783000.0 in Q1 2026 and bottomed at $638000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 17.21 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 5.74 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 6.92 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 1.38 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 101.60 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 1.89 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 2.98 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 1.56 Bn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | 766,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 766,000.00 |
| Mar 31, 2026 | 783,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 638,000.00 |
| Mar 31, 2025 | 650,000.00 |